Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies—Executive Summary

The use of immunosuppressive therapies for immune-mediated disease (IMD) is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due i...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Kim A, Haraoui, Boulos, Kumar, Deepali, Marshall, John K, Bissonnette, Robert, Bitton, Alain, Bressler, Brian, Gooderham, Melinda, Ho, Vincent, Jamal, Shahin, Pope, Janet E, Steinhart, A Hillary, Vinh, Donald C, Wade, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785689/
https://www.ncbi.nlm.nih.gov/pubmed/31616855
http://dx.doi.org/10.1093/jcag/gwy069
Descripción
Sumario:The use of immunosuppressive therapies for immune-mediated disease (IMD) is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive agents.

Ejemplares similares